Comparing two ultrasound reading methods for new liver spots after liver cancer treatment
Part of Cancer, Digestive system clinical trials.
This study compares two methods for reading contrast-enhanced ultrasound images to tell whether new liver spots after liver cancer treatment are cancer or not. If you have a new liver lesion after prior treatment, this scan may help doctors decide your next steps more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had liver cancer treatment in the past, such as surgery or ablation, and a new liver spot has appeared.
- The new liver spot was examined with a special ultrasound that uses a contrast agent.
- The new liver spot has a clear diagnosis, either from a biopsy or other standard tests.
- The ultrasound images of the new spot are clear enough to read.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special ultrasound with contrast dye to get a clearer picture of liver spots that other scans (CT, MRI, or PET) couldn't fully identify. The goal is to see if this ultrasound can help doctors make a more accurate diagnosis.
This trial compares two types of imaging scans (CEUS and AMRI) to see which one is better at finding liver cancer (HCC) in patients who have an unclear spot on their liver (an indeterminate nodule). It is for people with cirrhosis who have at least one such nodule but no confirmed liver cancer yet.
This study compares a shorter, non-contrast MRI and ultrasound to monitor for liver cancer in people with cirrhosis whose ultrasound images aren’t clear enough. It aims to see which method works better and may help you get safer, more reliable follow-up.
This study tests new criteria for evaluating how well thermal ablation (using heat to destroy cancer nodules) worked in people with hepatocellular carcinoma (HCC, a type of liver cancer). It aims to improve follow-up imaging with contrast-enhanced ultrasound (CEUS) or CT/MRI to see if the treatment was successful.
This study tests if a special ultrasound contrast agent can help find liver cancer earlier in people with cirrhosis. It compares this method with other imaging tests to improve early detection and treatment planning.
This study tests a new ultrasound technique to catch liver cancer sooner. If you have regular imaging checks for liver cancer or are getting an MRI for a liver spot, you may be able to join.
Hear when a new Contrast Enhanced Ultrasound trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.